Evidence map›Paper›PMID 27212661›Full record

ArticleCell host & microbe2016

Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection.

Wei Liu, Ruifeng Yang, Aimee S Payne, Rachel M Schowalter, Megan E Spurgeon, Paul F Lambert, Xiaowei Xu, Christopher B Buck, Jianxin You

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 1 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 1 synthesis or guideline pooled it, 172 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. EmergingFrontiers in cell and developmental biology · 2025
    Review

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wei LiuDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Ruifeng YangDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Aimee S PayneDepartment of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Rachel M SchowalterTumor Virus Molecular Biology Section, Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, MD 20892, USA.
Megan E SpurgeonDepartment of Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA.
Paul F LambertDepartment of Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA.
Xiaowei XuDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Christopher B BuckTumor Virus Molecular Biology Section, Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, MD 20892, USA.
Jianxin YouDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: jianyou@mail.med.upenn.edu.
University of Pennsylvania · USNational Cancer Institute · USUniversity of Wisconsin–Madison · US

Funding

Targeted Combination Therapy for MelanomaP50CA174523 · NCI · WISTAR INSTITUTE · PI HERLYN, MEENHARD F · 2014 to 2018
$11.1M
Molecular biology of human polyomavirusesZIABC011090 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI BUCK, CHRISTOPHER · 2009 to 2025
$9.3M
Merkel cell polyomavirus infection, host response, and viral oncogenic mechanismR01CA187718 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Jianxin You · 2015 to 2026
$3.7M
Virology Training ProgramT32AI078985 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI LAMBERT, PAUL F. · 2009 to 2018
$3.3M
Characterization of neural crest stem cells in human hair follicles.R01AR054593 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI XU, XIAOWEI · 2009 to 2013
$1.9M
Mechanism of Brd4-mediated papillomavirus host interactionsR01CA142723 · NCI · UNIVERSITY OF PENNSYLVANIA · PI YOU, JIANXIN · 2010 to 2014
$1.8M
Chromatin structure maintenance and cancerR01CA148768 · NCI · UNIVERSITY OF PENNSYLVANIA · PI YOU, JIANXIN · 2010 to 2014
$1.6M
Structure and Function of Human Pemphigus AutoantibodiesR56AR064220 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI PAYNE, AIMEE S · 2014 to 2014
$400k
NCI NIH HHS P50 CA174523NCI NIH HHS R01 CA142723NCI NIH HHS R01 CA148768NCI NIH HHS R01 CA187718NIAID NIH HHS T32 AI078985NIAMS NIH HHS R01 AR054593NIAMS NIH HHS R56 AR064220
6 · The paper itself

Abstract

Infection with Merkel cell polyomavirus (MCPyV) can lead to Merkel cell carcinoma (MCC), a lethal form of skin cancer. However, the skin cell type productively infected by MCPyV remains a central question. We combined cell culture and ex vivo approaches to identify human dermal fibroblasts as natural host cells that support productive MCPyV infection. Based on this, we established a cell culture model for MCPyV infection, which will facilitate investigation of the oncogenic mechanisms for this DNA virus. Using this model, we discovered that induction of matrix metalloproteinase (MMP) genes by the WNT/β-catenin signaling pathway and other growth factors stimulates MCPyV infection. This suggests that MCC risk factors such as UV radiation and aging, which are known to stimulate WNT signaling and MMP expression, may promote viral infection and thus drive MCC. Our study also introduces the FDA-approved MEK antagonist trametinib as an effective inhibitor for controlling MCPyV infection.

Indexed as

AdultCell LineCell Line, TumorCells, CulturedFibroblastsHumansInfantMaleMatrix MetalloproteinasesMerkel cell polyomavirusPolyomavirus InfectionsProtein Kinase InhibitorsRisk FactorsSignal TransductionSkinMatrix MetalloproteinasesProtein Kinase Inhibitors

Identifiers

PMID27212661
PMCPMC4900903
OpenAlexW2407801378

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.